USFDA revokes authorization of COVID antibody drugs of GSK, Lilly and 2 others Ruchika Sharma24 Dec 2024 12:30 PM ISTThe US Food and Drug Administration (USFDA) has revoked the emergency use authorisation for four Covid-19 antibody-based drugs from pharma...
USFDA withdraws emergency use authorization for AstraZeneca COVID 19 treatment Evusheld Ruchika Sharma27 Jan 2023 4:42 PM ISTAstraZeneca said it was informed that the agency will decide about reinstating authorization of Evusheld if the prevalence of resistant variants in...
COVID-19 Treatment : Eli Lilly's Bebtelovimab no longer authorized by USFDA Ruchika Sharma1 Dec 2022 3:30 PM ISTEli Lilly and its authorized distributors have paused the commercial distribution of the monoclonal antibody until further notice from the agency.
Eli Lilly bags USFDA emergency use nod for COVID drug Bebtelovimab Ruchika Sharma12 Feb 2022 2:52 PM ISTIndianapolis: Eli Lilly has recently announced that the company has received the Emergency Use Authorization (EUA) from the U.S. Food and Drug...
USFDA halts use of Regeneron, Lilly Covid-19 antibody treatments Ruchika Sharma25 Jan 2022 11:52 AM ISTNew Delhi: The U.S. health regulator revised on Monday the emergency use authorizations for COVID-19 antibody treatments from Regeneron and Eli...
